May 2, 2008 - Critical Outcome Technologies Inc. (TSX VENTURE:COT) announced that it has amalgamated with its wholly owned subsidiary, 6441513 Canada Inc, operating as DDP Therapeutics (DDP) effective May 1, 2008. DDP was acquired as announced on November 27, 2007. This amalgamation completes the process of integrating the small cell lung cancer (SCLC) molecule library of DDP with the research development operations of Critical Outcome Technologies Inc. (COTI)... [PDF] Critical Outcome Technologies' Press Release -
Showing posts with label Critical Outcome Technologies. Show all posts
Showing posts with label Critical Outcome Technologies. Show all posts
Jun 6, 2008
Critical Outcome Technologies : Amalgamation With DDP Therapeutics
May 2, 2008 - Critical Outcome Technologies Inc. (TSX VENTURE:COT) announced that it has amalgamated with its wholly owned subsidiary, 6441513 Canada Inc, operating as DDP Therapeutics (DDP) effective May 1, 2008. DDP was acquired as announced on November 27, 2007. This amalgamation completes the process of integrating the small cell lung cancer (SCLC) molecule library of DDP with the research development operations of Critical Outcome Technologies Inc. (COTI)... [PDF] Critical Outcome Technologies' Press Release -
Libellés :
Critical Outcome Technologies,
DDP Therapeutics,
Lung Cancer
Subscribe to:
Comments (Atom)